Proteomics

Dataset Information

0

PBAF loss leads to DNA damage induced inflammatory signalling through defective G2/M checkpoint maintenance


ABSTRACT: PBRM1 is a subunit of the PBAF (SWI/SNF) chromatin remodelling complex that is mutated in approximately 40% of clear cell renal cell carcinomas (ccRCC). PBRM1 loss has been implicated in the response to immune checkpoint inhibitor (ICI) therapy in ccRCC. However, it is unclear how PBRM1 influences this. DNA damage-induced inflammatory signalling is an important factor determining ICI therapy response. This response is kept in check by the G2/M checkpoint, which prevents progression through mitosis with unrepaired damage. Here, we show that PBRM1 is required for p53-dependent maintenance of the G2/M checkpoint. In its absence, p53-dependent transcriptional upregulation of p21 is delayed, leading to defective repression of DREAM complex targets and premature entry into mitosis. Consequently, DNA damage induced inflammatory signalling pathways are activated by cytosolic DNA. Notably, p53 is infrequently mutated in ccRCC, so PBRM1 mutational status is critical to G2/M checkpoint maintenance following DNA damage in this cancer. These findings have implications for ICI therapy responses in ccRCC.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: James Wright  

LAB HEAD: Jyoti Choudhary

PROVIDER: PXD028336 | Pride | 2022-10-13

REPOSITORIES: Pride

altmetric image

Publications

PBAF loss leads to DNA damage-induced inflammatory signaling through defective G2/M checkpoint maintenance.

Feng Hugang H   Lane Karen A KA   Roumeliotis Theodoros I TI   Jeggo Penny A PA   Somaiah Navita N   Choudhary Jyoti S JS   Downs Jessica A JA  

Genes & development 20220728


The PBRM1 subunit of the PBAF (SWI/SNF) chromatin remodeling complex is mutated in ∼40% of clear cell renal cancers. PBRM1 loss has been implicated in responses to immunotherapy in renal cancer, but the mechanism is unclear. DNA damage-induced inflammatory signaling is an important factor determining immunotherapy response. This response is kept in check by the G2/M checkpoint, which prevents progression through mitosis with unrepaired damage. We found that in the absence of PBRM1, p53-dependent  ...[more]

Similar Datasets

2008-06-15 | E-GEOD-7469 | biostudies-arrayexpress
2018-12-13 | MODEL1812130001 | BioModels
2022-11-23 | GSE211466 | GEO
2007-07-01 | GSE7469 | GEO
2021-12-20 | PXD023435 | Pride
2016-01-04 | E-GEOD-70530 | biostudies-arrayexpress
2024-09-02 | BIOMD0000000704 | BioModels
2020-10-06 | GSE145148 | GEO
2008-06-20 | E-GEOD-11436 | biostudies-arrayexpress
2010-04-11 | E-GEOD-12674 | biostudies-arrayexpress